RHOGAM ANTI-D - Rho(D) Immune Globulin

Ensure clinical safety and effective prophylaxis with RHOGAM ANTI-D. This Rho(D) immune globulin solution is a vital component in managing Rh-incompatibility, providing essential protection for Rh-negative individuals during pregnancy and blood transfusion procedures.

Specifications

Description and Clinical Use Cases

RHOGAM ANTI-D is a specialized medical solution indicated for the prevention of Rh isoimmunization. It is specifically designed for administration to Rh-negative women who have not been previously sensitized to the Rh(D) factor. This is a critical preventative measure in several obstetric and hematological scenarios.

Obstetrical Indications:

The use of this product is indicated in the following circumstances to protect the health of both mother and fetus:

• Delivery of an Rh-positive baby, regardless of the ABO groups of the mother and baby.
• Antepartum prophylaxis administered between 26 to 28 weeks of gestation.
• Management of suspected or proven antepartum fetal-maternal hemorrhage.
• Procedures involving potential blood exchange, such as amniocentesis, chorionic villus sampling, or percutaneous umbilical blood sampling.
• Management of actual or threatened pregnancy loss at any gestational stage.
• Ectopic pregnancy protocols.

Blood Transfusion Applications:

Beyond obstetrics, RHOGAM is essential for the prevention of Rh isoimmunization in any Rh-in나e person following the transfusion of Rh-incompatible blood or blood products. This includes the administration of:

• Red blood cells.
• Platelet concentrates.
• Granulocyte concentrates.

By utilizing this product, medical professionals can mitigate the risks associated with Rh-incompatibility, ensuring higher safety standards for patients undergoing specific blood-related or obstetric procedures.